Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function
- PMID: 18514160
- PMCID: PMC2427267
- DOI: 10.1016/j.ajhg.2008.04.019
Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function
Abstract
Thyroid-stimulating hormone (TSH) controls thyroid growth and hormone secretion through binding to its G protein-coupled receptor (TSHR) and production of cyclic AMP (cAMP). Serum TSH is a sensitive indicator of thyroid function, and overt abnormalities in thyroid function lead to common endocrine disorders affecting approximately 10% of individuals over a life span. By genotyping 362,129 SNPs in 4,300 Sardinians, we identified a strong association (p = 1.3 x 10(-11)) between alleles of rs4704397 and circulating TSH levels; each additional copy of the minor A allele was associated with an increase of 0.13 muIU/ml in TSH. The single-nucleotide polymorphism (SNP) is located in intron 1 of PDE8B, encoding a high-affinity cAMP-specific phosphodiesterase. The association was replicated in 4,158 individuals, including additional Sardinians and two genetically distant cohorts from Tuscany and the Old Order Amish (overall p value = 1.9 x 10(-20)). In addition to association of TSH levels with SNPs in PDE8B, our genome scan provided evidence for association with PDE10A and several biologically interesting candidates in a focused analysis of 24 genes. In particular, we found evidence for association of TSH levels with SNPs in the THRB (rs1505287, p = 7.3 x 10(-5)), GNAQ (rs10512065, p = 2.0 x 10(-4)), TG (rs2252696, p = 2.2 x 10(-3)), POU1F1 (rs1976324, p = 3.9 x 10(-3)), PDE4D (rs27178, p = 8.3 x 10(-3)), and TSHR (rs4903957, p = 8.6 x 10(-3)) loci. Overall, the results suggest a primary effect of PDE8B variants on cAMP levels in the thyroid. This would affect production of T4 and T3 and feedback to alter TSH release by the pituitary. PDE8B may thus provide a candidate target for the treatment of thyroid dysfunction.
Figures
References
-
- Kopp P. Thyroid hormone synthesis. In: Braverman L.E., Utiger R.D., editors. The Thyroid. A Fundamental and Clinical Text. Lippincott; New York: 2005. pp. 52–76.
-
- Yen P.M. Physiological and molecular basis of thyroid hormone action. Physiol. Rev. 2001;81:1097–1142. - PubMed
-
- Vassart G., Dumont J.E. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr. Rev. 1992;13:596–611. - PubMed
-
- Dahl G.E., Evans N.P., Thrun L.A., Karsch F.J. A central negative feedback action of thyroid hormones on thyrotropin-releasing hormone secretion. Endocrinology. 1994;135:2392–2397. - PubMed
-
- Barnett P. Somatostatin and somatostatin receptor physiology. Endocrine. 2003;20:255–264. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01-AG-821336/AG/NIA NIH HHS/United States
- U01 HL084729/HL/NHLBI NIH HHS/United States
- R01 MD009164/MD/NIMHD NIH HHS/United States
- 263 MD 821336/MD/NIMHD NIH HHS/United States
- R01 AG18728/AG/NIA NIH HHS/United States
- HG002651/HG/NHGRI NIH HHS/United States
- HL084729/HL/NHLBI NIH HHS/United States
- 263-MA-410953/PHS HHS/United States
- U01 HL072515/HL/NHLBI NIH HHS/United States
- N01-AG-916413/AG/NIA NIH HHS/United States
- R01 AG018728/AG/NIA NIH HHS/United States
- U01 HL72515/HL/NHLBI NIH HHS/United States
- N01-AG-1-2109/AG/NIA NIH HHS/United States
- R01 HG002651/HG/NHGRI NIH HHS/United States
- M01 RR 000052/RR/NCRR NIH HHS/United States
- M01 RR000052/RR/NCRR NIH HHS/United States
- M01 RR016500/RR/NCRR NIH HHS/United States
- 263 MD 916413/MD/NIMHD NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
